Cellsbin
1 known investors
CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications. The company serves researchers and clinicians in drug development, cell therapy monitoring, and clinical diagnostics.
Founders & leadership
AK
Ali KabiriinFounder
Investors · 1
Competitors · 3
by search overlapLabcorp4 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Cellbioengines4 shared keywordsCell BioEngines is a clinical-stage biotech company developing allogeneic "off-the-shelf" cell therapies from "super donor" stem cells, using transgene-free scalable manufacturing and HLA-guided design. It pursues stem cell-derived therapeutics across oncology and regenerative medicine.
Brukercellularanalysis4 shared keywordsBruker Cellular Analysis develops technologies for live single-cell biology research, combining optofluidics, live single-cell imaging, functional cell biology, and multiomic data to study cellular function and molecular mechanisms. It serves scientists in academia, biotech and pharmaceutical companies, and contract research organizations, supporting work in cell therapy, therapeutic antibody discovery, vaccine development, and cell line development.
Companies competing with Cellsbin for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cellsbin do?
- CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications. The company serves researchers and clinicians in drug development, cell therapy monitoring, and clinical diagnostics.
- Who founded Cellsbin?
- Cellsbin was founded by Ali Kabiri.
- Who are Cellsbin's investors?
- Cellsbin's investors include Connecticut Innovations.